James S. Wolffsohn

Prof. James S. Wolffsohn

Aston University, Birmingham, UK
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in The Ocular Surface
Verified
Journal Article
Closed access
James S. WolffsohnJames S. Wolffsohn
James S. Wolffsohn
RAReiko Arita
Reiko Arita
RCRobin Chalmers
Robin Chalmers
ADAli Djalilian
Ali Djalilian
MDMurat Dogru
Murat Dogru
JCJennifer P. Craig
Jennifer P. Craig

1 July 2017 in The Ocular Surface
Verified
Journal Article
Closed access
Lyndon JonesLyndon Jones
Lyndon Jones
LDLaura Downie
Laura Downie
DKDonald Korb
Donald Korb
JBJose M. Benitez-Del-Castillo
Jose M. Benitez-Del-Castillo
RDReza Dana
Reza Dana
JCJennifer P. Craig
Jennifer P. Craig

1 October 2017 in The Ocular Surface
Verified
Journal Article
Open access
Jennifer P CraigJennifer P Craig
Jennifer P Craig
JNJ. Daniel Nelson
J. Daniel Nelson
DADimitri T. Azar
Dimitri T. Azar
CBCarlos Belmonte
Carlos Belmonte
ABAnthony J. Bron
Anthony J. Bron
DSDavid A. Sullivan
David A. Sullivan
This article presents an Executive Summary of the conclusions and recommendations of the 10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July 2017 issue of The Ocular Surface. A downloadable version of the document and additional material, including videos of diagnostic and management techniques, are available on the TFOS website: www.TearFilm.org.

4 January 2022 in Contact Lens and Anterior Eye
Verified
Journal Article
Open access
JSJacinto Santodomingo-Rubido
Jacinto Santodomingo-Rubido
GCGonzalo Carracedo
Gonzalo Carracedo
ASAsaki Suzaki
Asaki Suzaki
CVCesar Villa-Collar
Cesar Villa-Collar
SVStephen J. Vincent
Stephen J. Vincent
James S. WolffsohnJames S. Wolffsohn
James S. Wolffsohn
Keratoconus is a bilateral and asymmetric disease which results in progressive thinning and steeping of the cornea leading to irregular astigmatism and decreased visual acuity. Traditionally, the condition has been described as a noninflammatory disease; however, more recently it has been associated with ocular inflammation. Keratoconus normally develops in the second and third decades of life and progresses until the fourth decade. The condition affects all ethnicities and both sexes. The prevalence and incidence rates of keratoconus have been estimated to be between 0.2 and 4,790 per 100,000 persons and 1.5 and 25 cases per 100,000 persons/year, respectively, with highest rates typically occurring in 20- to 30-year-olds and Middle Eastern and Asian ethnicities. Progressive stromal thinning, rupture of the anterior limiting membrane, and subsequent ectasia of the central/paracentral cornea are the most commonly observed histopathological findings. A family history of keratoconus, eye rubbing, eczema, asthma, and allergy are risk factors for developing keratoconus. Detecting keratoconus in its earliest stages remains a challenge. Corneal topography is the primary diagnostic tool for keratoconus detection. In incipient cases, however, the use of a single parameter to diagnose keratoconus is insufficient, and in addition to corneal topography, corneal pachymetry and higher order aberration data are now commonly used. Keratoconus severity and progression may be classified based on morphological features and disease evolution, ocular signs, and index-based systems. Keratoconus treatment varies depending on disease severity and progression. Mild cases are typically treated with spectacles, moderate cases with contact lenses, while severe cases that cannot be managed with scleral contact lenses may require corneal surgery. Mild to moderate cases of progressive keratoconus may also be treated surgically, most commonly with corneal cross-linking. This article provides an updated review on the definition, epidemiology, histopathology, aetiology and pathogenesis, clinical features, detection, classification, and management and treatment strategies for keratoconus.

1 July 2017 in The Ocular Surface
Verified
Journal Article
Closed access
CBCarlos Belmonte
Carlos Belmonte
JNJason J. Nichols
Jason J. Nichols
SCStephanie M. Cox
Stephanie M. Cox
JBJames A. Brock
James A. Brock
CBCarolyn G. Begley
Carolyn G. Begley
James S. WolffsohnJames S. Wolffsohn
James S. Wolffsohn

16 April 2018 in BMJ Open Ophthalmology
Verified
Journal Article
Open access
PDF file
ASAmy L Sheppard
Amy L Sheppard
James S. WolffsohnJames S. Wolffsohn
James S. Wolffsohn
Digital device usage has increased substantially in recent years across all age groups, so that extensive daily use for both social and professional purposes is now normal. Digital eye strain (DES), also known as computer vision syndrome, encompasses a range of ocular and visual symptoms, and estimates suggest its prevalence may be 50% or more among computer users. Symptoms fall into two main categories: those linked to accommodative or binocular vision stress, and external symptoms linked to dry eye. Although symptoms are typically transient, they may be frequent and persistent, and have an economic impact when vocational computer users are affected. DES may be identified and measured using one of several available questionnaires, or objective evaluations of parameters such as critical flicker–fusion frequency, blink rate and completeness, accommodative function and pupil characteristics may be used to provide indices of visual fatigue. Correlations between objective and subjective measures are not always apparent. A range of management approaches exist for DES including correction of refractive error and/or presbyopia, management of dry eye, incorporating regular screen breaks and consideration of vergence and accommodative problems. Recently, several authors have explored the putative role of blue light-filtering spectacle lenses on treating DES, with mixed results. Given the high prevalence of DES and near-universal use of digital devices, it is essential that eye care practitioners are able to provide advice and management options based on quality research evidence.